Search results
Showing 3016 to 3030 of 8900 results
The complete list of all our published indicators, for measuring outcomes that reflect the quality of care or processes, linked by evidence to improved outcomes.
Page 1 of 19 Taking a medicine to reduce the chance of developing breast cancer Decision aid for postmenopausal women at high risk Published
NICE has reviewed DMD Care UK’s guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations. We think the guideline from DMD Care UK is a useful resource that will help clinicians improve care in this area
Name: Consultant: (or affix hospital sticker) Patient decision aid Options for women referred to specialist centres Treating complications from mesh...
Abortion care. Patient decision aid on choosing between medical or surgical abortion before 14 weeks
Abortion Choosing between medical or surgical abortion before 14 weeks Most women and girls who have an abortion can choose how it will be carried out
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Home Get involved Our committees NICE committee meetings...
Read the biographies for all members of the NICE antimicrobial evaluation committee.
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
Tell us what matters to you, your organisation or your community.
Details and meeting dates of the antimicrobials evaluation panel
Biographies and registered interests for members of the Technology Appraisal Committee C
Find out more about NICE technology appraisals advisory committee D members
This indicator covers mortality rates directly associated with VTE. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG80
This indicator covers the percentage of patients who reached 75 years old in the preceding 12 months, who have received a shingles vaccine between the ages of 70 and 75 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM201